Topics and Expertise: recombinant antibodies

James Wells, PhD, whose pioneering innovations in protein engineering and technologies to identify small molecules to aid in drug discovery have yielded more than 60 patents, launched three companies, and created two UCSF technology centers, has been elected as a fellow to the National Academy of...

A new collaboration between Celgene Corp. and the Recombinant Antibody Network (RAN) will support the development of next-generation, antibody-based cancer therapies.